Baird Financial Group
CLLS

Baird Financial Group’s Cellectis CLLS Stock Holding History

Baird Financial Group’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,090
Closed -$31.6K – 1800
2025
Q3 		$31.6K Buy
+11,090
New +$28.7K ﹤0.01% 1787
2025
Q2 		– Sell
-15,090
Closed -$18.7K – 1783
2025
Q1 		$18.7K Hold
15,090
– – ﹤0.01% 1750
2024
Q4 		$27.2K Hold
15,090
– – ﹤0.01% 1743
2024
Q3 		$32K Hold
15,090
– – ﹤0.01% 1734
2024
Q2 		$28.2K Buy
+15,090
New +$39.6K ﹤0.01% 1743
2022
Q4 		– Sell
-32,640
Closed -$74K – 1694
2022
Q3 		$74K Buy
+32,640
New +$98.9K ﹤0.01% 1681

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Baird Financial Group's CLLS Position: Q4 2025 in Review

Baird Financial Group sold out of Cellectis (CLLS) in Q4 2025, closing a stake of 11,090 shares — an estimated $31.6K sold.

Baird Financial Group first reported a position in CLLS in Q3 2022 and held it in 6 quarters. The position peaked at $74K in Q3 2022. 34 funds tracked by Wall St. Rank hold CLLS as of Q4 2025.

  • Baird Financial Group reported no remaining Cellectis position as of Q4 2025 after selling out during the quarter.
  • Baird Financial Group sold 11,090 Cellectis shares in Q4 2025, an estimated $31.6K.
  • Baird Financial Group first reported a position in Cellectis in Q3 2022 and held it in 6 quarters.
  • Baird Financial Group's Cellectis position peaked at $74K in Q3 2022.
  • 34 funds tracked by Wall St. Rank held Cellectis as of Q4 2025.

Based on Baird Financial Group's 13F filing for Q4 2025, filed 13 Feb 2026.